147 filings
Page 6 of 8
8-K
db9s74a83bz4vefi
19 Apr 16
OncoSec Presents Positive Melanoma Clinical Data at American Association for Cancer Research (AACR) Annual Meeting 2016
12:00am
8-K
1zqzqdc
15 Apr 16
OncoSec Announces New Senior Leadership Responsibilities
12:00am
8-K
crtb2j4w
8 Mar 16
OncoSec Announces Second Quarter and YTD Results for Fiscal Year 2016 and Calendar 2016 Milestones
12:00am
8-K
gs12w0rb22 pd2n
26 Jan 16
Termination of a Material Definitive Agreement
12:00am
8-K
cxetv8b 3r
29 Dec 15
Departure of Directors or Certain Officers
12:00am
8-K
8c61o62sg8gfps2k5ge1
9 Dec 15
OncoSec Announces First Quarter Results for Fiscal Year End 2016
12:00am
8-K
okioqgte3r7sxx20ug8w
7 Dec 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
2h0pmdo69z4c7wch
5 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
r3ssnm11tlq73
30 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
zsshdwevas4dbp
30 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
d4p5sfmvq7nvq
15 Oct 15
OncoSec Announces Fourth Quarter and YTD Results for Fiscal Year End 2015
12:00am
8-K
bw3l3kgrj 266qnawp6
5 Oct 15
Other Events
12:00am
8-K
fgebnjgx
5 Aug 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
zq8m 34toio
25 Jun 15
OncoSec Medical Appoints Richard B. Slansky as Chief Financial Officer
12:00am
8-K
jjb4tda14r6ispnddmv
9 Jun 15
Results of Operations and Financial Condition
12:00am
8-K
8eqo xcv4rfr0dn
4 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
ly4 0tjx8sihq
15 May 15
OncoSec Medical Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market
12:00am
8-K
u7d689ld
12 Mar 15
OncoSec Medical Announces Six Months Results for Fiscal Year End 2015
12:00am
8-K
kc8u5jpxl1hdhllswjy
11 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
098kt4bv5q228yk63e0w
2 Jan 15
Entry into a Material Definitive Agreement
12:00am